Cargando…
Histone deacetylase inhibition attenuates hepatic steatosis in rats with experimental Cushing's syndrome
Cushing's syndrome (CS) is a collection of symptoms caused by prolonged exposure to excess cortisol. Chronically elevated glucocorticoid (GC) levels contribute to hepatic steatosis. We hypothesized that histone deacetylase inhibitors (HDACi) could attenuate hepatic steatosis through glucocortic...
Autores principales: | Kim, Mina, Lee, Hae-Ahm, Cho, Hyun-Min, Kang, Seol-Hee, Lee, Eunjo, Kim, In Kyeom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746509/ https://www.ncbi.nlm.nih.gov/pubmed/29302209 http://dx.doi.org/10.4196/kjpp.2018.22.1.23 |
Ejemplares similares
-
Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats
por: Lee, Eunjo, et al.
Publicado: (2016) -
Histone Deacetylase Inhibition Attenuates Aortic Remodeling in Rats under Pressure Overload
por: Jung, Hanna, et al.
Publicado: (2020) -
Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats
por: Cho, Hyun Min, et al.
Publicado: (2018) -
Histone Deacetylase 3 and 4 Complex Stimulates the Transcriptional Activity of the Mineralocorticoid Receptor
por: Lee, Hae-Ahm, et al.
Publicado: (2015) -
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
por: Li, Xiaohua, et al.
Publicado: (2019)